According to the Zhitong Finance App, Kang Fang Biotech (09926.HK) announced that on July 24, 2026, the company granted 3.6 million share options to 167 grantees under the share option plan. The exercise price of each share option was HK$99.5. On the same day, the company granted 1,648,500 restricted share units to 162 grantees in accordance with the 2021 Restricted Share Units Plan, which is subject to acceptance by the grantees.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.